Predictive Value of the Prostate-specific Antigen Doubling Time for the Effectiveness of Metastasis-directed Radiotherapy in Patients With Oligometastases After Radical Treatment for Non-metastatic Prostate Cancer
MDRT can provide benefit especially for patients with PSADT ≥3 months who had oligo-recurrence after the radical treatment for non-metastatic prostate cancer.
Authors
- Kazumasa Matsumoto (ORCID: https://orcid.org/0000-0003-0564-4764)
- Ken‐ichi Tabata
- Yuzuru Niibe
- Shuhei Hirano (ORCID: https://orcid.org/0009-0007-6851-8665)
- Takefumi Satoh (ORCID: https://orcid.org/0000-0003-3616-5010)
- Dai Koguchi (ORCID: https://orcid.org/0000-0003-0731-2579)
- MASATSUGU IWAMUR
- M. Ikeda
- SOICHIRO SHIMURA
Institutions
- Kurume University (JP)
- Kitasato Institute Hospital (JP)
- Kitasato University (JP)
Publication Details
- Journal
- Cancer Diagnosis & Prognosis
- Published
- 2024-09-01
- DOI
- https://doi.org/10.21873/cdp.10375
- Citations
- 1
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- Japan Society for the Promotion of Science